Health & Medicine
-
Mali Reports 21 Dengue Deaths and 600 Cases, Health Director Says
Health officials in Mali announced that, by early December 2023, the country had documented 600 confirmed cases of dengue fever and at…
-
Mali Reports 21 Deaths, 600 Cases in Dengue Fever Surge
Health authorities in Mali have recorded a sharp increase in dengue fever cases as of December 6, 2023, with at least 21…
-
988 Suicide and Crisis Lifeline Handled Five Million Contacts in 2023
United States, December 1, 2023 — infopulsetoday.com — As of November 28, 2023, individuals in the United States can continue to access…
-
Ghanaian Physician Wins Award for Expanding Abortion Access in Africa
On 29 November 2023, Eunice Brookman‑Amissah stepped onto a stage in Stockholm to receive the Right Livelihood Award, a prize often described…
-
WHO Seeks Data on Mysterious Pneumonia Outbreak in Northern China
The World Health Organization has requested information from Chinese authorities regarding a surge in pediatric pneumonia cases in northern China, marking a…
-
WHO Seeks Info on China’s Respiratory Disease Surge in Children
On 22 November 2023 the World Health Organization formally requested that Chinese health authorities supply detailed information about a recent increase in…
-
FDA Approves Lung Cancer Drug Augtyro for ROS1-Positive Tumors, Trial Shows Responses
The U.S. Food and Drug Administration granted approval on November 15, 2023, for Repotrectinib, marketed as Augtyro, to treat a defined group…
-
FDA Approves Capivasertib Oral Drug With Fulvestrant for Advanced Breast Cancer With Specific Gene Changes
On 15 November 2023, the U.S. Food and Drug Administration gave its approval to capivasertib, marketed under the name Truqap, for a…
-
Capivasertib approved in US as Truqap for breast cancer treatment
On November 15, 2023, a significant development was announced in the field of cancer treatment with the approval of capivasertib, an anti-cancer…
-
AbbVie to Acquire ImmunoGen for $10.1 Billion, Adding Ovarian Cancer Drug Elahere
On a Wednesday in mid-November, AbbVie decided it would pay $10.1 billion for ImmunoGen. That is a lot of money for a…
-
EU Approves BeiGene’s Tevimbra for Advanced Oesophageal Cancer After Chemotherapy
On 15 September 2023 the European Union gave the green light to Tislelizumab, a PD‑1‑targeting monoclonal antibody that has been available in…
-
WHO Puts Highly Mutated BA.2.86 Covid Variant Under Monitoring
July 30, 2023 — cybernewschronicle.com — The detection of BA.2.86 on July 24, 2023, is not simply another entry in the long…
-
US Approves New Multiple Myeloma Treatment Option Elrexfio Medication
On 15 August 2023, U.S. health authorities granted approval to a new therapy for multiple myeloma, a blood‑cancer that remains difficult to…
-
FDA Approves New Oral Pill Zuranolone for Postpartum Depression
On August 15, 2023, the United States Food and Drug Administration granted approval to Zuranolone, a medication that will be marketed under…
-
FDA Grants Accelerated Approval to Talquetamab, a T-Cell Engager for Myeloma
For patients with multiple myeloma who have run out of options, August 15, 2023, changed the calculus. That day, regulators in the…
-
Talquetamab Wins FDA Accelerated Approval, Then European Approval, for Relapsed Multiple Myeloma
United States, August 16, 2023 — cybernewschronicle.com — On August 15, 2023, the medical community marked a significant milestone with the approval…
-
City of Hope Drug AOH1996 Moves Through Early Human Trial After Mouse Study Results
An investigational cancer medication called AOH1996 has entered Phase I clinical trials at City of Hope as of August 15, 2023, marking…
-
FDA Grants Accelerated Approval to Elrexfio for Heavily Treated Multiple Myeloma
/ HTML. So we need headings maybe and paragraphs . Must not add any extra info. Must keep facts: FDA approved Elranatamab…
-
South African variant: Beta strain B.1.351 impact on COVID-19 immunity
The South African variant refers to several variants of SARS-CoV-2, a virus that has been closely monitored globally due to its potential…
-
Fatty liver disease: New classification and understanding as of June 2023
Fatty liver disease (FLD), a condition characterized by the buildup of excess fat in the liver, has been a subject of increasing…
-
Breakthrough in Synthetic Embryo Research Offers New Miscarriage Insights
In the United States, tens of thousands of pregnancies end in miscarriage each year, yet the underlying causes often remain unknown. While…
-
Cholera Outbreak Reported in South Africa Since February 2023
South Africa is currently managing a cholera outbreak that first surfaced on 1 February 2023. Since the emergence of these initial cases,…
-
Swiss Brain Implant Allows Paralyzed Man to Walk Naturally
On May 24, 2023, researchers in Switzerland announced a significant medical milestone. A man who had been paralyzed regained the ability to…
-
Swiss Brain Implants Let Paralyzed Man Walk Naturally
A groundbreaking medical breakthrough has been achieved by Swiss scientists, who have successfully enabled a paralyzed man to walk naturally through the…
Most read
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Experimental Drug Combo Doubles One-Year Survival Rates in Pancreatic Cancer Trial
-
Factor XIa Inhibitor Asundexian Cuts Recurrent Stroke Risk Without Raising Major Bleeding
-
UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Why Achieve Says Most Americans Feel Their Financial Stability is Slipping Away
-
Locking In High Yields: How Current CD Rates Offer Safe Returns Amid Shifting Economic Outlooks
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
-
India’s NPPA slashes 137 cancer drug prices by up to 96%, saving ₹3,500 crore annually
-
Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992